WILLIAM FIELDING: Open Payments
NPI 1154345015 · CLIFTON PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$571 in 36 payments from 11 companies in 2025. Trend: 2023 $668 · 2024 $1,148 · 2025 $571
Food & beverage: $571
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $225 |
| Novo Nordisk Inc | 3 | $66 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| Abbott Laboratories | 2 | $41 |
| Phathom Pharmaceuticals, Inc. | 3 | $37 |
| Amgen Inc. | 2 | $29 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Dexcom, Inc. | 1 | $20 |
Products named: UBRELVY, VRAYLAR, Wegovy, TRELEGY ELLIPTA, QULIPTA, FREESTYLE LIBRE 3, VOQUEZNA, GARDASIL 9.
Industry payments across NY — which companies pay providers there.
